ATE390428T1 - Neue oripavinderivate und deren verwendungen als arzneimittel - Google Patents

Neue oripavinderivate und deren verwendungen als arzneimittel

Info

Publication number
ATE390428T1
ATE390428T1 AT02764501T AT02764501T ATE390428T1 AT E390428 T1 ATE390428 T1 AT E390428T1 AT 02764501 T AT02764501 T AT 02764501T AT 02764501 T AT02764501 T AT 02764501T AT E390428 T1 ATE390428 T1 AT E390428T1
Authority
AT
Austria
Prior art keywords
methyl
new
medicinal products
oripavine derivatives
cycloalkyl
Prior art date
Application number
AT02764501T
Other languages
German (de)
English (en)
Inventor
B Zhong
Z Gong
Y Wang
Y Liu
B Qin
Original Assignee
Inst Pharm & Toxicology Amms
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Pharm & Toxicology Amms filed Critical Inst Pharm & Toxicology Amms
Application granted granted Critical
Publication of ATE390428T1 publication Critical patent/ATE390428T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02764501T 2001-09-14 2002-09-13 Neue oripavinderivate und deren verwendungen als arzneimittel ATE390428T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011421495A CN1233645C (zh) 2001-09-14 2001-09-14 新的东罂粟碱衍生物及其医药用途

Publications (1)

Publication Number Publication Date
ATE390428T1 true ATE390428T1 (de) 2008-04-15

Family

ID=4676657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02764501T ATE390428T1 (de) 2001-09-14 2002-09-13 Neue oripavinderivate und deren verwendungen als arzneimittel

Country Status (8)

Country Link
EP (1) EP1439179B1 (https=)
JP (1) JP4532109B2 (https=)
CN (1) CN1233645C (https=)
AT (1) ATE390428T1 (https=)
DE (1) DE60225827D1 (https=)
MX (1) MXPA04002422A (https=)
WO (1) WO2003024972A1 (https=)
ZA (1) ZA200402733B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
EP1981891B1 (en) 2006-01-05 2009-09-02 Mallinckrodt, Inc. The use of oripavine as a starting material for buprenorphine
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
KR20110014974A (ko) * 2008-03-31 2011-02-14 썬 파마슈티컬 인더스트리스 리미티드 모르피난 유사체의 개선된 제조 방법
PL2342207T3 (pl) 2008-09-30 2016-05-31 SpecGx LLC Sposoby alkilowania norbuprenorfiny ze zmniejszonym powstawaniem zanieczyszczeń
NZ607842A (en) 2008-09-30 2013-12-20 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
EP2342208B1 (en) * 2008-09-30 2014-06-04 Mallinckrodt LLC Recycling process for increasing the yield of a grignard reaction in the preparation of opiate alkaloid derivatives
US8232397B2 (en) 2008-09-30 2012-07-31 Mallinckrodt Llc Processes for the production of buprenorphine with reduced impurity formation
CA2738089C (en) 2008-09-30 2017-07-18 Mallinckrodt Inc. Processes for the hydrogenation of opiate alkaloid derivatives
US8232396B2 (en) 2008-09-30 2012-07-31 Mallinckrodt Llc Processes for the synthesis of opiates alkaloids with reduced impurity formation
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
CN102462680B (zh) * 2010-11-04 2016-08-03 中国人民解放军军事医学科学院毒物药物研究所 噻吩诺啡的长效缓释微球及其组合物和制备方法
CN102382118A (zh) * 2011-05-23 2012-03-21 浙江仙琚制药股份有限公司 一种7ɑ-乙酰基-6,14-乙基桥四氢蒂巴因的制备方法
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
EP3023427A1 (en) 2014-11-19 2016-05-25 Siegfried AG Improved method of manufacturing buprenorphine and analogues thereof from oripavine
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
GB2550566A (en) 2016-05-19 2017-11-29 Chapelglade Ltd Mattress evaluation system and method
CN108530452B (zh) * 2017-03-01 2023-02-03 泰州华元医药科技有限公司 高效抗成瘾药物
EP4613751A1 (en) 2024-03-07 2025-09-10 Siegfried AG Method of making chemical compounds useful for the synthesis of buprenorphine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB925723A (en) * 1960-09-05 1963-05-08 J F Macfarlan & Company Ltd Novel thebaine derivatives
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물

Also Published As

Publication number Publication date
DE60225827D1 (de) 2008-05-08
WO2003024972A1 (en) 2003-03-27
EP1439179B1 (en) 2008-03-26
EP1439179A1 (en) 2004-07-21
EP1439179A4 (en) 2005-10-12
JP4532109B2 (ja) 2010-08-25
WO2003024972A8 (en) 2004-06-17
CN1233645C (zh) 2005-12-28
CN1408714A (zh) 2003-04-09
JP2005506985A (ja) 2005-03-10
ZA200402733B (en) 2005-02-23
MXPA04002422A (es) 2005-04-11

Similar Documents

Publication Publication Date Title
ATE390428T1 (de) Neue oripavinderivate und deren verwendungen als arzneimittel
AU2134402A (en) Antiviral agents
SE9904508D0 (sv) New compounds
ATE233761T1 (de) Neue chinuclidin-derivate und diese enthaltende pharmazeutische präparate
DE60000120D1 (de) Bicyclische Carbonyl-Indolverbindungen als entzündungshemmende/ analgetische Wirkstoffe und als COX-2 Inhibitoren
HUT64336A (en) Methods for producing new thiazole-benzofurane derivatives and pharmaceutical preparatives containing them
HUP9801883A2 (hu) Farnezil-protein transzferáz enzim gátló piperazinszármazékok, előállításuk, alkalmazásuk, és a vegyületeket tartalmazó gyógyszerkészítmények
IL144483A0 (en) Chemical compounds
ATE247654T1 (de) Neue heterozyklische verbindungen
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
EP0915094A4 (en) MORPHINANE DERIVATIVES AND MEDICAL USE THEREOF
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
HUT46536A (en) Process for producing antianxietive pharmaceutical compositions
EP1084711A4 (en) REMEDIES, CONTAINING PGD 2 ANTAGONISTS
CA2465871A1 (en) Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
IL99305A (en) 4-substituted dihydropyrido [4,3-d]pyrimidines their preparation and analgesic and topical antiinflammatory compositions containing them for the treatment of skin disorders
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
HUT49879A (en) Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
HUP9901910A2 (hu) Orfanin FQ(OFQ) receptor agonista és/vagy antagonista di- vagy tri-aza-spiro[4,5]dekán-származékok, előállításuk és alkalmazásuk
ES2100768T3 (es) Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
IL143873A0 (en) Dry skin remedies
DE69523819D1 (de) Quinolin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
GB8610369D0 (en) Heterocyclic compounds
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties